Delirium associated with lithium-quetiapine combination

Clinical Neuropharmacology

Volumn 31, Issue 3, 2008, Pages 176-179

  Miodownik, Chanoch ^a   Alkatnany, Awad ^a   Frolova, Katherina ^a   Lerner, Vladimir ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b MENTAL HEALTH CENTER   (Israel)

Author keywords

Adverse events; Combination therapy; Delirium; Lithium; Quetiapine

Indexed keywords

DIAZEPAM; HALOPERIDOL; LITHIUM CARBONATE; QUETIAPINE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DELIRIUM; DRUG DOSE INCREASE; DRUG WITHDRAWAL; HUMAN; LABORATORY TEST; MALE; NEUROLOGIC EXAMINATION; NEUROTOXICITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCHIZOPHRENIA; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; DELIRIUM; DIAZEPAM; DIBENZOTHIAZEPINES; DRUG THERAPY, COMBINATION; HALOPERIDOL; HUMANS; HYPNOTICS AND SEDATIVES; LITHIUM; MALE; MIDDLE AGED; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME; WITHHOLDING TREATMENT;

EID: 44649113781     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e31814a619d     Document Type: Article

References (33)

1. Harvey NS, Merriman S. Review of clinically important drug interactions with lithium. Drug Saf 1994;10:455-463.
2. Meyer MC, Baldessarini RJ, Goff DC, et al. Clinically significant interactions of psychotropic agents with antipsychotic drugs. Drug Saf 1996;15:333-346.
3. Baastrup PC, Hollnagel P, Sorensen R, et al. Adverse reactions in treatment with lithium carbonate and haloperidol. JAMA 1976;236:2645-2646.
4. Binder EF, Cayabyab L, Ritchie DJ, et al. Diltiazem-induced psychosis and a possible diltiazem-lithium interaction. Arch Intern Med 1991;151:373-374.
5. Evans M, Marwick P. Fluvoxamine and lithium: an unusual interaction [letter]. Br J Psychiatry 1990;156:286.
6. Normann C, Brandt C, Berger M, et al. Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction. Pharmacopsychiatry 1998;31:201-204.
7. Slordal L, Samstad S, Bathen J, et al. A life-threatening interaction between lithium and celecoxib [letter]. Br J Clin Pharmacol 2003;55:413-414.
8. MacDonald J, Neale TJ. Toxic interaction of lithium carbonate and mefenamic acid [letter]. BMJ 1988;297:1339.
9. Noveske FG, Hahn KR, Flynn RJ. Possible toxicity of combined fluoxetine and lithium [letter]. Am J Psychiatry 1989;146:1515.
10. Salama AA, Shafey M. A case of severe lithium toxicity induced by combined fluoxetine and lithium carbonate [letter]. Am J Psychiatry 1989;146:278.
11. Austin LS, Arana GW, Melvin JA. Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients. J Clin Psychiatry 1990;51:344-345.
12. Thornton WE, Pray BJ. Lithium intoxication: a report of two cases. Can Psychiatr Assoc J 1975;20:281-282.
13. Alevizos B. Toxic reactions to lithium and neuroleptics [letter]. Br J Psychiatry 1979;135:482.
14. Spring G, Frankel M. New data on lithium and haloperidol incompatibility. Am J Psychiatry 1981;138:818-821.
15. Marhold J, Zimanova J, Lachman M, et al. To the incompatibility of haloperidol with lithium salts. Act Nerv Super (Praha) 1974;16:199-200.
16. Prakash R, Kelwala S, Ban TA. Neurotoxicity with combined administration of lithium and a neuroleptic. Compr Psychiatry 1982;23:567-571.
17. Blake LM, Marks RC, Luchins DJ. Reversible neurologic symptoms with clozapine and lithium. J Clin Psychopharmacol 1992;12:297-299.
18. Swanson CL, Jr, Price WA, McEvoy JP. Effects of concomitant risperidone and lithium treatment [letter]. Am J Psychiatry 1995;152:1096.
19. Miodownik C, Hausmann M, Frolova K, et al. Lithium intoxication associated with intramuscular ziprasidone in schizoaffective patients. Clin Neuropharmacol 2005;28:295-297.
20. Apseloff G, Mullet D, Wilner KD, et al. The effects of ziprasidone on steady-state lithium levels and renal clearance of lithium. Br J Clin Pharmacol 2000;49(suppl 1):61S-64S.
21. Finley PR, Warner MD, Peabody CA. Clinical relevance of drug interactions with lithium. Clin Pharmacokinet 1995;29:172-191.
22. Miodownik C, Lerner V. Quetiapine: efficacy, tolerability and safety in schizophrenia. Expert Rev Neurother 2006;6:983-992.
23. Potkin SG, Thyrum PT, Bera R, et al. Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability. Clin Ther 2002;24:1809-1823.
24. -atham LN, Paulsson B, Mullen J, et al. Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. J Clin Psychopharmacol 2004;24:599-606.
25. Patten SB, Williams JV, Petcu R, et al. Delirium in psychiatric inpatients: a case-control study. Can J Psychiatry 2001;46:162-166.
26. Emilien G, Maloteaux JM. Lithium neurotoxicity at low therapeutic doses Hypotheses for causes and mechanism of action following a retrospective analysis of published case reports. Acta Neurol Belg 1996;96:281-293.
27. Niethammer R, Keller A, Weisbrod M. [Delirium syndrome as a side-effect of lithium in normal lithium levels] [in German]. Psychiatr Prax 2000;27:296-297.
28. Omata N, Murata T, Omori M, et al. A patient with lithium intoxication developing at therapeutic serum lithium levels and persistent delirium after discontinuation of its administration. Gen Hosp Psychiatry 2003;25:53-55.
29. Honig PK, Cantilena LR. Polypharmacy. Pharmacokinetic perspectives. Clin Pharmacokinet 1994;26:85-90.
30. Lang EJ, Davis SM. Lithium neurotoxicity: the development of irreversible neurological impairment despite standard monitoring of serum lithium levels. J Clin Neurosci 2002;9:308-309.
31. Kumar R, Deb JK, Sinha BN, et al. Lithium toxicityVa descriptive study. Indian J Psychiatry 2001;43:52-57.
32. Tuglu C, Erdogan E, Abay E. Delirium and extrapyramidal symptoms due to a lithium-olanzapine combination therapy: a case report. J Korean Med Sci 2005;20:691-694.
33. Mukherjee BP, Bailey PT, Pradhan SN. Temporal and regional differences in brain concentrations of lithium in rats. Psychopharmacology (Berl) 1976;48:119-121.